Myomo® Receives First Australian Insurance Authorization for MyoPro™

03Sep

Myomo® Receives First Australian Insurance Authorization for MyoPro™

Portfolio News
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that a Myomotrained Orthotic & Prosthetic (“O&P”) practice in Australia has received its first insurance authorization to fit a patient with a custom MyoPro device. Read more >>

Share this post

Related Posts

23Jun

Savvy Shopper: How to save money when buying toys

Let’s face it, toys are expensive. But they help to stimulate, educate, and occupy our busy kids when we need... read more
08Jul

Myomo Announces Second Quarter Preliminary Revenue and Record Pipeline Additions

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,... read more
19Feb

These high-tech glasses let the legally blind see

eSight is releasing a new product on Tuesday that helps blind people see. The glasses, which look similar to a... read more
29Aug

The microbial functional feed that’s proving its worth

Knip has developed a precision fermentation platform that produces ingredients for aquafeeds using a natural, abundantly available microbe – if... read more
26Jan

Wasabi CEO sees more debt financing deals ahead for cloud storage business

David Friend, CEO and co-founder of cloud storage provider Wasabi Technologies Inc. said last week's debt raise will finance the... read more
20Dec

Walmart’s 2016 holiday videos on YouTube have earned over 75M views – Insight from Pixability

Walmart’s push on YouTube this holiday season is paying off, earning the brand more than 75 million video views for... read more
05Jan

eSight wants to help 50 million people living with vision loss see by 2020

Toronto-based eSight has launched a pledge to help the 50 million people worldwide living with vision loss and blindness by... read more
19Dec

Corbus Pharma (CRBP) Announces Issuance of Composition of Matter Patent Related to Lenabasum

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a clinical stage drug development company with the industry’s leading pipeline focused on treating... read more
09Feb

WiLS Partners with Scrible to Help Wisconsin Schools Affordably Access its Research and Writing Super App

Scrible, the super app that streamlines the research and writing process for students and educators, announced today its partnership with... read more
16May

Corbus Pharmaceuticals Announces Acceptance of Three Abstracts for Presentation at EULAR 2018 Annual Meeting

Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to... read more